Sponsor or institution
Clinical trials and research at HRYZ Biotech Co.
As of November 12, 2026, Find a Trial lists 2 clinical trials run by HRYZ Biotech Co. that are recruiting, in China. By phase: Phase 1 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
MASCT-I plus doxorubicin and ifosfamide as first-line treatment for advanced soft tissue sarcoma
This trial will test whether adding MASCT-I to standard chemotherapy (doxorubicin and ifosfamide) helps adults with advanced soft tissue sarcoma respond better or live longer.
-
HRYZ-T101 injection for HPV18 positive solid tumors
This study is testing a new injection called HRYZ-T101 to see if it can safely help people with solid tumors that are positive for HPV18.
Quick answers
How many clinical trials run by HRYZ Biotech Co. are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.